INTERCEPT PHARMACEUTICALS IN (ICPT) Stock Analyst Ratings
NASDAQ:ICPT - Nasdaq - US45845P1084 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 70% to ICPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.38. This target is 2% above the current price.
ICPT was analyzed by 20 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about ICPT.
In the previous month the buy percentage consensus was at a similar level.
ICPT was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-27 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-09-27 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2023-09-27 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2023-09-27 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-08-03 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-07-13 | HC Wainwright & Co. | Upgrade | Sell -> Buy |
| 2023-06-29 | Canaccord Genuity | Upgrade | Hold -> Buy |
| 2023-06-26 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-06-15 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-05-30 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-05-23 | Needham | Downgrade | Buy -> Hold |
| 2023-05-23 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-05-23 | B of A Securities | Maintains | Underperform -> Underperform |
| 2023-05-22 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-05-22 | Baird | Maintains | Outperform -> Outperform |
| 2023-05-22 | HC Wainwright & Co. | Downgrade | Neutral -> Sell |
| 2023-05-18 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-04-28 | Raymond James | Maintains | Outperform |
| 2023-04-10 | Piper Sandler | Maintains | Overweight |
| 2023-03-06 | Raymond James | Maintains | Outperform |
| 2023-03-03 | Needham | Maintains | Buy |
| 2023-03-03 | RBC Capital | Maintains | Sector Perform |
| 2023-03-03 | SVB Leerink | Maintains | Market Perform |
| 2023-02-15 | RBC Capital | Maintains | Sector Perform |
| 2023-01-20 | Raymond James | Maintains | Outperform |
| 2022-11-16 | HC Wainwright & Co. | Maintains | Neutral |
| 2022-11-02 | Raymond James | Maintains | Outperform |
| 2022-10-03 | SVB Leerink | Maintains | Market Perform |
| 2022-10-03 | Baird | Maintains | Outperform |